|
One Thousand Lives A Month
Researcher Estimates 22,000 Lives Could Have Been Saved Had Trasylol Been Pulled Earlier
Source: http://www.cbsnews.com/stories/2008/02/14/60minutes/main3831900.shtml
Possible Trasylol Insiders Should Contact Americas Watchdog ...
Emediawire (press release), WA - Mar 21, 2008
Because of numerous horror story's in the national press, about the drug called Trasylol, Americas Watchdog has initiated a national investigation focused ...
One Thousand Lives A Month
Source: http://www.emediawire.com/releases/2008/3/prweb789524.htm
Trasylol Gone for Good
Trasylol is being removed from the market for good. Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart surgery, in November, after a clinical trial found patients treated with Trasylol were dying at higher rates than others. Now, the results of that trial are in, and the death risk has been confirmed. Yesterday, Bayer notified the Food & Drug Administration (FDA) that it was removing... |
Trasylol Named in 78 Lawsuits, Bayer Says
Bayer AG has been hit with 78 lawsuits over the drug Trasylol. In November, Bayer suspended Trasylol sales after a Canadian study linked it to a higher risk of death.Trayslol was approved in 1993, and was used to prevent bleeding during open heart surgeries. Since its approval, about a third of all heart surgery patients in the US have been treated with Trasylol. Trayslol was the subject of several Food & Drug Administration... |
More Trasylol Studies -- One Previously Withheld by Bayer -- Confirm Death Risks
Two more Trasylol studies have concluded that heart surgery patients are more likely to die if treated with the defective drug. Trasylol, manufactured by Bayer AG, was the subject of several Food & Drug Administration (FDA) safety reviews before it was finally pulled from the market last year. One of the newly released studies was completed prior to a September 2006 FDA advisory panel meeting on Trasylol, but was never submitted by... |
FDA Trasylol Failure Could Have Killed Thousands, Researcher Says
Trasylol, a defective drug manufactured by Bayer AG, may have killed 22,000 people before it was pulled from the market last year. Trasylol was withdrawn in November at the request of the Food & Drug Administration (FDA) after an observational study linked the medicine to kidney failure requiring dialysis and increased death of those patients. But a researcher who presented a Trasylol study to the FDA in 2006 told the TV program... |
Trasylol Drug Combo Linked to Deaths
A new Trasylol study is shedding more light on possible reasons behind the drug’s higher-than normal death rate. According to British researchers, while use of the clotting drug aprotinin—known as Trasylol—appears safe during on-pump cardiac surgeries, it appears that combining it with angiotensin-converting enzyme inhibitors—or ACE inhibitors—during off-pump cardiac surgeries shows a significant risk of... |
Trasylol Sales Suspended After Canadian Study Links Drug to Sudden Death Risk
Trasylol, a drug used to prevent bleeding during heart surgery, was removed from the market by Bayer AG earlier this month after it was linked to a risk of sudden death. According to the Food & Drug Administration, Trasylol may have been responsible for more than 200 fatalities.The Canadian Data Safety Monitoring Board had stopped a Trasylol trial - known as the BART clinical study - after a data analysis indicated that the 30-day... |
Trasylol Deaths Exceed 200, FDA Says
Trasylol, a defective drug made by Bayer AG, may have killed more than 200 people, according to the Food & Drug Administration (FDA). Trasylol, used to prevent bleeding during heart surgeries, was pulled from the market earlier this month, after it was linked to an increased risk of death.The FDA had asked Bayer to suspend sales of Trasylol, known generically as aprotinin, after a clinical trial involving the drug was halted. The... |
|
